Patients Before Middlemen Act
Senate Bill Would Overhaul Medicare Drug Middlemen, Require Full Rebate Pass-Through to Patients
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- This bill aims to lower costs and increase pharmacy choices for people on Medicare by changing how 'middlemen,' known as pharmacy benefit managers, are allowed to make money. It requires these companies to be paid flat fees for their services rather than taking a percentage of high drug prices.
- The policy would require Medicare drug plans to allow any pharmacy to join their network as long as the pharmacy agrees to standard contract terms. This is designed to help independent and local drugstores stay in business and ensure seniors don't have to travel long distances to get their prescriptions.
- Starting in 2028, drug middlemen would be forced to pass 100% of the rebates and discounts they get from drug makers directly to the insurance plans. This prevents these companies from keeping secret profits that could otherwise be used to lower premiums or out-of-pocket costs for patients.
- The bill creates special protections for 'essential' pharmacies in rural or underserved areas. The government would track how much these local shops are being paid compared to large mail-order pharmacies owned by the insurance companies to ensure fair treatment.
- To ensure honesty, the bill gives insurance plans the right to audit their drug middlemen at least once a year. It also allows pharmacies to report unfair contracts to the government without fear of being punished or kicked out of the network.
- If a drug middleman breaks these rules, they could face expensive government fines. Any illegal profits they made would have to be paid back to the Medicare drug plan.
Impact Analysis
Personal Impact
Life & Work
Independent pharmacies, many of which are small businesses, stand to benefit significantly. The bill's "any willing pharmacy" rule means drug plans must accept any pharmacy that meets standard terms, preventing PBMs from shutting out local pharmacies in favor of their own mail-order or specialty affiliates. New protections against unfair contract terms, a government complaint process, and anti-retaliation rules give small pharmacy owners leverage they currently lack against powerful PBMs.
Programs
Disabilities
Milestones
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
4 articles
What new PBM reforms mean for pharma
The Consolidated Appropriations Act of 2026 introduces new regulations for PBMs, including delinking compensation in Medicare Part D from drug list prices and requiring 'reasonable and relevant' contracts for all pharmacies. Starting in 2028, PBMs must pass through 100% of manufacturer rebates.
PBM Reform Within 2026 Appropriations Bill Signed Into Law
President Trump signed the Consolidated Appropriations Act of 2026 on Feb. 3, codifying key PBM reforms. The law restricts Part D remuneration to flat-dollar service fees starting in 2028 and mandates 100% pass-through of rebates to employer plans while strengthening pharmacy network protections.
PBM Reforms, Restoration of Science Cuts Seen in $1.2T Spending Deal for 2026
The $1.2 trillion spending package passed in February 2026 includes a package of reforms for pharmacy benefit managers. These provisions prohibit price-linked remuneration in Medicare Part D, require 100% rebate pass-through, and ensure reasonable pharmacy network contracting standards.
Source Information
Document Type
Congressional Bill
Official Title
Patients Before Middlemen Act
Data Sources
Sponsor
Cosponsors
(7)Political Response
Analysis generated by AI. Always verify with official sources.